سعر ساليبت مرهم 30 جرام Betamethasone 0.05% 2024

Salibet ointment 30 g (Jamjoom Pharmaceuticals): betamethasone 0.05% (as dipropionate) with salicylic acid 3% w/w, a potent topical corticosteroid combined with a keratolytic, listed in Egypt.

• Hyperkeratotic and dry corticosteroid-responsive dermatoses, e.g. psoriasis, chronic atopic dermatitis, neurodermatitis, lichen planus, eczema (including nummular and hand eczema), dyshidrosis, seborrhoeic dermatitis of the scalp, ichthyosis vulgarisPopulation: Adults and children

• Local burning, itching, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral and allergic contact dermatitis; with prolonged or occlusive use skin maceration, secondary infection, skin atrophy, striae and miliaria; salicylic acid may cause dermatitis.International label, same formulation

• Rosacea, acne vulgaris, perioral dermatitis, perianal and genital pruritus; primary cutaneous viral infections (e.g. herpes simplex, chickenpox); untreated fungal or bacterial skin infections; hypersensitivity to any component; dermatoses in infants under one year including napkin eruptions.International label, same formulation

• Systemic absorption with HPA-axis suppression, Cushing's syndrome and hyperglycaemia can occur, especially with large areas, prolonged use, occlusion or in children; avoid eyes and mucous membranes; visual disturbance (e.g. central serous chorioretinopathy) has been reported with corticosteroids.International label, same formulation
• In psoriasis, topical corticosteroids may cause rebound relapse, tolerance or generalised pustular psoriasis; careful supervision is needed.International label, same formulation

• There are limited data in pregnant women; topical corticosteroids should not be used extensively, in large amounts or for prolonged periods in pregnancy; use only if the benefit justifies the potential risk.International label, same formulation
• Safety in breastfeeding has not been established; use only if clearly needed and do not apply to the breasts before breastfeeding.International label, same formulation

• Betamethasone dipropionate: Topical corticosteroids share anti-inflammatory, antipruritic and vasoconstrictive actions via intracellular glucocorticoid receptor-mediated gene regulation of inflammatory mediators. Percutaneous absorption increases with inflammation and occlusion.
• Salicylic acid: